New Metathesis Catalysts
The Catalysts Business Line of Evonik has expanded its portfolio of metathesis catalysts. It is offering its customers three new, efficient homogeneous catalysts that cover a broad spectrum of reactions in cross-metathesis, ring-closing metathesis, and ring-opening metathesis: catMETium RF2, catMETium RF3, and catMETium RF4. In the chemical industry, metathesis is an important method for developing and producing, for example, high-tech plastics-including those based on renewable resources-or active ingredients for medicines and pesticides. Accordingly, the primary areas of application for the new catalysts are polymer chemistry and the pharmaceutical and agricultural industries. Ring-closing metathesis, for instance, is an indispensable reaction step in the synthesis of active ingredients for hepatitis C and cancer medications. Ring-opening cross-metathesis can be used to manufacture highly effective light-guiding polymer materials.
Evonik markets the new catalysts based on a proven, straightforward business model that requires no licensing agreements and ensures transparency. The total kilogram price for the catalysts already includes the licensing fees for the use of the intellectual property rights. The customer makes no additional commitments, and the name of the business model reflects its approach: The abbreviation "RF" stands for "royalty free." "This model allows the customer to use the new catalysts without limitations," says Dr. Jürgen Krauter, head of marketing in Evonik's Catalysts Business Line.
